Ontology highlight
ABSTRACT:
SUBMITTER: Patel GB
PROVIDER: S-EPMC7416524 | biostudies-literature | 2020 May
REPOSITORIES: biostudies-literature
The journal of allergy and clinical immunology. In practice 20200128 5
Advances in understanding the pathogenic mechanisms of both rhinitis and chronic rhinosinusitis have resulted in new treatment options, especially for chronic rhinosinusitis. A review of relevant medical and surgical clinical studies shows that intranasal corticosteroids, antihistamines, and allergen immunotherapy continue to be the best treatments for chronic rhinitis. Dupilumab is the first biologic approved for chronic rhinosinusitis with polyps. Omalizumab, mepolizumab, and benralizumab may ...[more]